Exercise for Depression and Anxiety During Pregnancy
(PIP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether regular physical activity can improve mental health in pregnant individuals with symptoms of depression or anxiety. Participants will divide into two groups: one group will aim to walk 8,000 steps a day, while the other will track their steps without a specific goal. It suits those pregnant with one baby, receiving prenatal care, and experiencing a history or current signs of depression or anxiety. The trial seeks to determine if increased movement can reduce stress and improve mood during pregnancy. As an unphased trial, this study provides a unique opportunity to contribute to understanding how lifestyle changes can enhance mental well-being during pregnancy.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this physical activity intervention is safe for pregnant individuals?
Research shows that exercising during pregnancy is usually safe and well-tolerated. Studies have found that exercise can boost mood and lower the risk of depression and anxiety. For example, one review found that high levels of physical activity reduced the chances of developing depression by about 32% and anxiety by about 33%. No evidence suggests harm to the pregnancy when exercise is done safely and there are no medical reasons to avoid it. In fact, exercise during pregnancy is linked to better overall outcomes. Regular physical activity, such as aiming for a step count goal, is considered safe for most pregnant individuals.12345
Why are researchers excited about this trial?
Researchers are excited about using exercise as a treatment for depression and anxiety during pregnancy because it offers a natural and accessible approach compared to traditional medications and therapies. Unlike antidepressants or therapy sessions that can be costly and have potential side effects, this physical activity intervention encourages expectant mothers to reach a daily step count goal, promoting overall well-being without medication. By personalizing the step goals and providing regular support, this method empowers pregnant women to take an active role in their mental health, potentially offering a safe and effective alternative to manage symptoms during pregnancy.
What evidence suggests that this physical activity intervention is effective for improving mental health in pregnant people with depression or anxiety?
Research shows that exercise can significantly reduce depression symptoms in pregnant women. In this trial, one group of participants will aim for a daily step count of 8,000 steps to encourage physical activity. Studies have found that staying active during pregnancy lowers the risk of postpartum depression. Moderate exercise is especially beneficial for the mental health of expecting mothers. Overall, exercising during pregnancy is safe and offers many benefits.24567
Who Is on the Research Team?
Danielle M Panelli, MD, MS
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for pregnant individuals with symptoms of depression or anxiety who are receiving prenatal care at Stanford Children's Health Obstetrics Clinic and have a single pregnancy. Details on who can't join are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a physical activity intervention with a step count goal or usual step count monitoring from 20 to 36 weeks of gestation
Follow-up
Participants are monitored for mental health and biological markers of stress, as well as pregnancy and neonatal complications
What Are the Treatments Tested in This Trial?
Interventions
- Physical Activity Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator